338 related articles for article (PubMed ID: 19219651)
1. Radiation recall dermatitis after pre-sensitization with pegylated liposomal doxorubicin.
Gzell CE; Carroll SL; Suchowerska N; Beith J; Tan K; Scolyer RA
Cancer Invest; 2009 May; 27(4):397-401. PubMed ID: 19219651
[TBL] [Abstract][Full Text] [Related]
2. An illustrated case of doxorubicin-induced radiation recall dermatitis and a review of the literature.
Haas RL; de Klerk G
Neth J Med; 2011 Feb; 69(2):72-5. PubMed ID: 21411843
[TBL] [Abstract][Full Text] [Related]
3. Radiation recall dermatitis after treatment of stage IV breast cancer with nivolumab: a case report.
Billena C; Padia S; O'Brien B; Knoble J; Gokhale A; Rajagopalan M
Immunotherapy; 2020 Feb; 12(2):123-130. PubMed ID: 31992119
[TBL] [Abstract][Full Text] [Related]
4. An intertrigo-like eruption from pegylated liposomal doxorubicin.
Korver GE; Ronald H; Petersen MJ
J Drugs Dermatol; 2006 Oct; 5(9):901-2. PubMed ID: 17039658
[TBL] [Abstract][Full Text] [Related]
5. Successful rechallenge after ixabepilone-induced radiation recall dermatitis using an alternative dosing strategy.
Ford JN; Newton M; Jordan C; Abraham J
J Oncol Pharm Pract; 2013 Mar; 19(1):89-92. PubMed ID: 22323422
[TBL] [Abstract][Full Text] [Related]
6. Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy -- case report and review of literature.
Putnik K; Stadler P; Schäfer C; Koelbl O
Radiat Oncol; 2006 Sep; 1():32. PubMed ID: 16948841
[TBL] [Abstract][Full Text] [Related]
7. [Radiotherapy-induced pemphigus].
Correia MP; Santos D; Jorge M; Coutinho S
Acta Med Port; 1998 Jun; 11(6):581-3. PubMed ID: 9773540
[TBL] [Abstract][Full Text] [Related]
8. Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer.
Minisini AM; Andreetta C; Fasola G; Puglisi F
Expert Rev Anticancer Ther; 2008 Mar; 8(3):331-42. PubMed ID: 18366282
[TBL] [Abstract][Full Text] [Related]
9. Phase II multicenter trial of anthracycline rechallenge with pegylated liposomal doxorubicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines.
Trudeau ME; Clemons MJ; Provencher L; Panasci L; Yelle L; Rayson D; Latreille J; Vandenberg T; Goel R; Zibdawi L; Rahim Y; Pouliot JF
J Clin Oncol; 2009 Dec; 27(35):5906-10. PubMed ID: 19858391
[TBL] [Abstract][Full Text] [Related]
10. Pegylated liposomal doxorubicin (caelyx) in metastatic breast cancer: a community-based observation study.
Salzberg M; Thurlimann B; Hasler U; Delmore G; von Rohr A; Thurlimann A; Ruhstaller T; Stopatschinskaja S; von Moos R
Oncology; 2007; 72(3-4):147-51. PubMed ID: 18087175
[TBL] [Abstract][Full Text] [Related]
11. Histologic patterns of polyethylene glycol-liposomal doxorubicin-related cutaneous eruptions.
Cady FM; Kneuper-Hall R; Metcalf JS
Am J Dermatopathol; 2006 Apr; 28(2):168-72. PubMed ID: 16625083
[TBL] [Abstract][Full Text] [Related]
12. Skin problems associated with pegylated liposomal doxorubicin-more than palmoplantar erythrodysesthesia syndrome.
Mangana J; Zipser MC; Conrad C; Oberholzer PA; Cozzio A; Knuth A; French LE; Dummer R
Eur J Dermatol; 2008; 18(5):566-70. PubMed ID: 18693162
[TBL] [Abstract][Full Text] [Related]
13. Metastatic breast cancer: the role of pegylated liposomal doxorubicin after conventional anthracyclines.
Verma S; Dent S; Chow BJ; Rayson D; Safra T
Cancer Treat Rev; 2008 Aug; 34(5):391-406. PubMed ID: 18358614
[TBL] [Abstract][Full Text] [Related]
14. Radiation recall dermatitis after docetaxel administration: absolute indication to replace the drug?
Borgia F; Guarneri C; Guarneri F; Vaccaro M
Br J Dermatol; 2005 Sep; 153(3):674-5. PubMed ID: 16120169
[No Abstract] [Full Text] [Related]
15. Radiation recall dermatitis induced by pegylated liposomal doxorubicin.
Jimeno A; Ciruelos EM; Castellano D; Caballero B; Rodriguez-Peralto JL; Cortés-Funes H
Anticancer Drugs; 2003 Aug; 14(7):575-6. PubMed ID: 12960743
[No Abstract] [Full Text] [Related]
16. Radiation recall reaction induced by levofloxacin.
Cho S; Breedlove JJ; Gunning ST
J Drugs Dermatol; 2008 Jan; 7(1):64-7. PubMed ID: 18246700
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous mastocytosis extending beyond a radiotherapy site: a form of radiodermatitis or a neoplastic phenomenon?
Davidson SJ; Coates D
Australas J Dermatol; 2013 Nov; 54(4):e85-7. PubMed ID: 23094593
[TBL] [Abstract][Full Text] [Related]
18. Skin-sparing intensity-modulated radiotherapy of the breast.
Vordermark D
J Clin Oncol; 2008 Jul; 26(19):3292; author reply 3292-3. PubMed ID: 18591570
[No Abstract] [Full Text] [Related]
19. Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy.
Osako T; Oguchi M; Kumada M; Nemoto K; Iwase T; Yamashita T
Jpn J Clin Oncol; 2008 May; 38(5):334-8. PubMed ID: 18417501
[TBL] [Abstract][Full Text] [Related]
20. Radiation recall dermatitis after the use of the anorexiant phentermine in a patient with breast cancer.
Ash RB; Videtic GM
Breast J; 2006; 12(2):186-7. PubMed ID: 16509853
[No Abstract] [Full Text] [Related]
[Next] [New Search]
